title: Prospects for dengue vaccines for travelers.
abstract: Travel-acquired dengue cases have been increasing as the overall global dengue burden has expanded. In Korea, imported dengue cases have been reported since 2000 when it first became a notifiable disease. During the first four months of 2016, three times more dengue cases were reported in Korea than during the same period the previous year. A safe and efficacious vaccine for travelers would be beneficial to prevent dengue disease in individual travelers and potentially decrease the risk of virus spread to non-endemic areas. Here, we summarize the characteristics of dengue vaccines for travelers and review dengue vaccines currently licensed or in clinical development.
authors.affiliation: International Vaccine Institute, Seoul, Korea.
authors.forename: Sl-Ki
authors.identifier: 0000-0003-2246-6824
authors.initials: SK
authors.lastname: Lim
authors.affiliation: International Vaccine Institute, Seoul, Korea.
authors.forename: Yong Seok
authors.identifier: 0000-0002-9633-654X
authors.initials: YS
authors.lastname: Lee
authors.affiliation: International Vaccine Institute, Seoul, Korea.
authors.forename: Suk
authors.identifier: 0000-0002-2220-6785
authors.initials: S
authors.lastname: Namkung
authors.affiliation: International Vaccine Institute, Seoul, Korea.
authors.forename: Jacqueline K
authors.identifier: 0000-0001-6744-7825
authors.initials: JK
authors.lastname: Lim
authors.affiliation: International Vaccine Institute, Seoul, Korea.
authors.forename: In-Kyu
authors.identifier: 0000-0001-5077-6470
authors.initials: IK
authors.lastname: Yoon
keywords: Dengue; Dengue vaccines; Travel